Zhengye Biotechnology-AZYBT
13F holders, Q1 2025 (March 31)3holders
$5.38avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Zhengye Biotechnology-A (ZYBT) in their 13F filings. The largest holders were UBS Group AG ($7K), Morgan Stanley ($247) and Tower Research Capital LLC (TRC) ($5).
- Company
- Zhengye Biotechnology-A
- CUSIP
- G989MS101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $7K |
| Exits | 0 | $0 |
Ownership 3 holders
| UBS Group AG | 0.00% | New | 1,289 | $7K |
| Morgan Stanley | 0.00% | New | 46 | $247 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is ZYBT's weight in each manager's 13F, not the share of Zhengye Biotechnology-A the manager owns.